Open access
Sep 2026
A decade of chronic hepatitis E treatment: Ribavirin effectiveness, safety, and the association of Torque Teno Virus load with treatment outcomes.
BACKGROUND Hepatitis E virus (HEV) affects immunocompromised individuals. Unlike immunocompetent hosts, who rarely develop chronic infection, up to two-thirds of immunocompromised patients progress to chronicity. Ribavirin is the recommended antiviral therapy, yet predictors of sustained virological response (SVR) rema...
G. Roo-Brand, E. Verschuuren, M. Knoester et al.
· Journal of Clinical Virology · 1 citation